DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L)

Clinical trials for DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L) explained in plain language.

Never miss a new study

Get alerted when new DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L) trials appear

Sign up with your email to follow new studies for DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Early cancer drug trial halted after initial safety testing

Disease control Terminated

This early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was termina…

Matched conditions: DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L)

Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L)

Get alerted when new DNA POLYMERASE EPSILON MUTATED TUMORS (P286R AND V411L) trials appear

Early cancer drug trial halted after initial safety testing